-
FDA Authorizes Novavax's Covid Shots as Mix-And-Match Booster to Pfizer Or Moderna
Novavax’s Covid shots rely on protein technology used in other vaccines for decades, rather than the messenger RNA used in the Pfizer and Moderna vaccines.
-
Novavax COVID Vaccine: Company Submits FDA Application for Booster Authorization
A new COVID vaccine will now be available in the U.S. after health officials recommended it Tuesday.
-
Novavax COVID Vaccine: Why It's Different From Others, When Shots Could Begin
A new COVID vaccine will now be available in the U.S. after health officials recommended it Tuesday.
-
CDC Recommends Novavax COVID-19 Vaccine for Adults
The CDC has recommended the Novavax COVID-10 vaccine for adults ages 18 and up, providing more options and flexibility for the public.
-
US Regulators OK New COVID-19 Shot Option From Novavax
The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults.
-
Novavax COVID Vaccine: What Makes It Different, When Shots Could Begin
Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions. Novavax received approval from the Food and Drug Administration for its COVID-19 vaccine Wednesday.
-
Pfizer Says Tweaked COVID-19 Shots Boost Omicron Protection
Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection.
-
CDC Approves COVID-19 Vaccines for Youngest Kids
A Centers for Disease Control and Prevention advisory committee on Saturday endorsed Pfizer-BioNTech and Moderna’s Covid-19 vaccines for young children, the last step before Director Dr. Rochelle Walensky can issue her final signoff.
-
US Opens COVID Vaccine to Little Kids, Shots Begin This Week
U.S. health officials have opened COVID-19 vaccines for infants, toddlers and preschoolers — the last group without the shots.
-
FDA Advisory Panel Recommends Moderna, Pfizer COVID Vaccines for Young Kids
The United States is one step closer to allowing young children to receive COVID vaccine doses, as an advisory panel for the Food and Drug Administration unanimously voted to recommend both the Pfizer and Moderna vaccines for children under the age of 6.